BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orcutt ST, Anaya DA. Liver Resection and Surgical Strategies for Management of Primary Liver Cancer. Cancer Control 2018;25:1073274817744621. [PMID: 29327594 DOI: 10.1177/1073274817744621] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Kong J, Wang T, Shen S, Zhang Z, Yang X, Wang W. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma. PeerJ 2019;7:e7942. [PMID: 31687273 DOI: 10.7717/peerj.7942] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yu S, Gao W, Zeng P, Chen C, Zhang Z, Liu Z, Liu J. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments. Biomed Pharmacother 2021;139:111612. [PMID: 33915505 DOI: 10.1016/j.biopha.2021.111612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ni JS, Zheng H, Huang ZP, Hong YG, Ou YL, Tao YP, Wang MC, Wang ZG, Yang Y, Zhou WP. MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma. Oncol Lett 2019;17:2317-27. [PMID: 30675297 DOI: 10.3892/ol.2018.9848] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
4 Teng WN, Wu HL, Tai YH, Lei HJ, Tsou MY, Chang KY. Group-based trajectory analysis of postoperative pain and outcomes after liver cancer surgery. J Chin Med Assoc 2021;84:95-100. [PMID: 33177401 DOI: 10.1097/JCMA.0000000000000446] [Reference Citation Analysis]
5 Yacoub JH, Hsu CC, Fishbein TM, Mauro D, Moon A, He AR, Bashir MR, Burke LMB. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. Abdom Radiol (NY) 2021;46:3528-39. [PMID: 33835223 DOI: 10.1007/s00261-021-03069-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lou Y, Liang B, Gu Q, He Z, Ramirez G. Bispectral-Based Ultrasound Image Restoration Algorithm for Neurological Disorders Analysis in Patients Anesthetized with Sevoflurane. Scientific Programming 2021;2021:1-7. [DOI: 10.1155/2021/9975089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ning J, Ye Y, Bu D, Zhao G, Song T, Liu P, Yu W, Wang H, Li H, Ren X, Ying G, Zhao Y, Yu J. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther 2021;29:2067-87. [PMID: 33601054 DOI: 10.1016/j.ymthe.2021.02.016] [Reference Citation Analysis]
8 Lin H, Peng J, Zhu T, Xiong M, Zhang R, Lei L. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25. Front Oncol 2022;12:759864. [PMID: 35756606 DOI: 10.3389/fonc.2022.759864] [Reference Citation Analysis]
9 He M, Zhang P, Ma X, He B, Fang C, Jia F. Radiomic Feature-Based Predictive Model for Microvascular Invasion in Patients With Hepatocellular Carcinoma. Front Oncol. 2020;10:574228. [PMID: 33251138 DOI: 10.3389/fonc.2020.574228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li X, Guan Q, Shang Y, Wang Y, Lv S, Yang Z, Wang R, Feng Y, Li W, Li Y. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. WJG 2021;27:4203-15. [DOI: 10.3748/wjg.v27.i26.4203] [Reference Citation Analysis]
11 Jiang H, Tang W, Song Y, Jin W, Du Q. Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma. Front Pharmacol 2022;13:806175. [PMID: 35308206 DOI: 10.3389/fphar.2022.806175] [Reference Citation Analysis]
12 Wei Y, Lin Y, Chen W, Liu S, Jin L, Huang D. Computational and In Vitro Analysis of Plumbagin's Molecular Mechanism for the Treatment of Hepatocellular Carcinoma. Front Pharmacol 2021;12:594833. [PMID: 33912033 DOI: 10.3389/fphar.2021.594833] [Reference Citation Analysis]
13 Xu H, Xiong C, Chen Y, Zhang C, Bai D. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Bioengineered 2021;12:2664-75. [PMID: 34115569 DOI: 10.1080/21655979.2021.1938470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhang S, Zhao G, Dong H. Effect of Radiofrequency Ablation with Interventional Therapy of Hepatic Artery on the Recurrence of Primary Liver Cancer and the Analysis of Influencing Factors. J Oncol 2021;2021:3392433. [PMID: 34691177 DOI: 10.1155/2021/3392433] [Reference Citation Analysis]
15 Liu JG, Wang J, Sun W, Zhang JJ, Wang YJ, Shu GM, Lou C, Du Z. ALPPS in the treatment of liver cancer with insufficient future liver remnant. Hepatobiliary Pancreat Dis Int 2021;20:400-2. [PMID: 33952408 DOI: 10.1016/j.hbpd.2021.04.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hildebrand N, Verkoulen K, Dewulf M, Heise D, Ulmer F, Coolsen M. Short-term outcomes of laparoscopic versus open hepatectomy in the elderly patient: systematic review and meta-analysis. HPB (Oxford) 2021;23:984-93. [PMID: 33632653 DOI: 10.1016/j.hpb.2021.01.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Álvarez-Mercado AI, Caballeria-Casals A, Rojano-Alfonso C, Chávez-Reyes J, Micó-Carnero M, Sanchez-Gonzalez A, Casillas-Ramírez A, Gracia-Sancho J, Peralta C. Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection. Biomedicines 2021;9:1158. [PMID: 34572344 DOI: 10.3390/biomedicines9091158] [Reference Citation Analysis]
18 Li K, Peng Y, Tian H, He H. Value of spiral CT multi-parameter combined preoperative evaluation of microvascular invasion in small liver cancer. Pak J Med Sci 2021;37:1605-9. [PMID: 34712291 DOI: 10.12669/pjms.37.6-WIT.4851] [Reference Citation Analysis]
19 Fan W, Yang X, Huang F, Tong X, Zhu L, Wang S. Identification of CD206 as a potential biomarker of cancer stem-like cells and therapeutic agent in liver cancer. Oncol Lett 2019;18:3218-26. [PMID: 31452799 DOI: 10.3892/ol.2019.10673] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 M Cunha G, Fowler KJ, Roudenko A, Taouli B, Fung AW, Elsayes KM, Marks RM, Cruite I, Horvat N, Chernyak V, Sirlin CB, Tang A. How to Use LI-RADS to Report Liver CT and MRI Observations. Radiographics 2021;41:1352-67. [PMID: 34297631 DOI: 10.1148/rg.2021200205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Patel K, Lamm R, Altshuler P, Dang H, Shah AP. Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy. Int J Mol Sci 2020;21:E6757. [PMID: 32942580 DOI: 10.3390/ijms21186757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Panayotova G, Guerra J, Guarrera JV, Lunsford KE. The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma. J Clin Med 2021;10:2428. [PMID: 34070772 DOI: 10.3390/jcm10112428] [Reference Citation Analysis]
23 Fu R, Yu F, Wu W, Liu J, Li J, Guo F, Xu L, Wang F, Cui X. Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding. Int Immunopharmacol 2021;101:108195. [PMID: 34678691 DOI: 10.1016/j.intimp.2021.108195] [Reference Citation Analysis]
24 Ho VL, Pham NH, Nguyen TX, Tran AP, Dang NT, Pham NH. Hepatectomy with Takasaki's Technique Using SonaStar Ultrasonic Aspiration System: An Experience from 58 Cases. Clin Exp Gastroenterol 2021;14:297-302. [PMID: 34188512 DOI: 10.2147/CEG.S319434] [Reference Citation Analysis]
25 Gao X, Wang Y, Li Y, Wang Y, Yan M, Sun H, Chen S, Pan X. Huganpian, a traditional chinese medicine, inhibits liver cancer growth in vitro and in vivo by inducing autophagy and cell cycle arrest. Biomed Pharmacother 2019;120:109469. [PMID: 31698319 DOI: 10.1016/j.biopha.2019.109469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
26 Lurje I, Czigany Z, Bednarsch J, Roderburg C, Isfort P, Neumann UP, Lurje G. Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach. Int J Mol Sci 2019;20:E1465. [PMID: 30909504 DOI: 10.3390/ijms20061465] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
27 Zhou B, Chen TW, Jiang YB, Wei XB, Lu CD, Li JJ, Xie D, Cheng SQ. Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma. Oncol Lett 2020;19:2011-20. [PMID: 32194697 DOI: 10.3892/ol.2020.11262] [Reference Citation Analysis]
28 Wang Q, Qian B, Schäfer M, Groß W, Mehrabi A, Ryschich E. Fluorescence-guided fiber-optic micronavigation using microscopic identification of vascular boundary of liver segment and tumors. Theranostics 2020;10:6136-48. [PMID: 32483444 DOI: 10.7150/thno.45973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Nazemian S, Nabaei M. Numerical investigation of the effect of vascular network complexity on the efficiency of cryosurgery of a liver tumor. International Journal of Thermal Sciences 2020;158:106569. [DOI: 10.1016/j.ijthermalsci.2020.106569] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, Wang R, Wang T, Qiu Y, Yu H. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother 2021;133:111044. [PMID: 33378952 DOI: 10.1016/j.biopha.2020.111044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yu J, Wu ZZ, Li T, Xu Y, Zhao YC, Zhang BL, Tian H. Effectiveness of surgical resection for complicated liver cancer and its influencing factors: A retrospective study. World J Clin Cases 2020; 8(4): 736-742 [PMID: 32149057 DOI: 10.12998/wjcc.v8.i4.736] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Gao R, Zhao S, Aishanjiang K, Cai H, Wei T, Zhang Y, Liu Z, Zhou J, Han B, Wang J, Ding H, Liu Y, Xu X, Yu Z, Gu J. Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data. J Hematol Oncol 2021;14:154. [PMID: 34565412 DOI: 10.1186/s13045-021-01167-2] [Reference Citation Analysis]
33 Jiao XL, Li SC, Hao L, Wang TG, Chen JF. Cost-benefit analysis of hepatic resection, radiofrequency ablation and liver transplantation in small hepatocellular carcinoma. Expert Rev Pharmacoecon Outcomes Res 2021;:1-7. [PMID: 34433363 DOI: 10.1080/14737167.2021.1973432] [Reference Citation Analysis]
34 Tang Z, Tang Y, Liu T, Liu R, Xie S, Xie D, Yang J, Tang Y. Clinical Study on the Efficacy of Laparoscopic Hepatectomy and Its Influence on the Expression of Serum VEGF, FGF, and Immune Function. Evid Based Complement Alternat Med 2021;2021:4432022. [PMID: 34650612 DOI: 10.1155/2021/4432022] [Reference Citation Analysis]
35 Kampalath R, Tran-Harding K, Do RKG, Mendiratta-Lala M, Yaghmai V. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy. Magn Reson Imaging Clin N Am 2021;29:389-403. [PMID: 34243925 DOI: 10.1016/j.mric.2021.05.013] [Reference Citation Analysis]
36 Chen T, Tu Y, Lv D, Lin K, Tang H, Huang W. Vacuolar protein sorting-associated protein 72 homolog (VPS72) binding to lysine acetyltransferase 5 (KAT5) promotes the proliferation, invasion and migration of hepatocellular carcinoma through regulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Bioengineered 2022;13:9197-210. [PMID: 35383533 DOI: 10.1080/21655979.2022.2056692] [Reference Citation Analysis]
37 Wehling C, Dill MT, Olkus A, Springfeld C, Chang DH, Naumann P, Longerich T, Kratochwil C, Mehrabi A, Merle U, Pfeiffenberger J, Rupp C, Weiss KH, Mieth M. Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities. J Cancer Res Clin Oncol 2021;147:2471-81. [PMID: 33537908 DOI: 10.1007/s00432-021-03528-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zhang Y, Qu Y, Chen Y. Influence of 6-shogaol potentiated on 5-fluorouracil treatment of liver cancer by promoting apoptosis and cell cycle arrest by regulating AKT/mTOR/MRP1 signalling. Chinese Journal of Natural Medicines 2022;20:352-63. [DOI: 10.1016/s1875-5364(22)60174-2] [Reference Citation Analysis]
39 Li XY, Guan QX, Shang YZ, Wang YH, Lv SW, Yang ZX, Wang R, Feng YF, Li WN, Li YJ. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 2021; 27(26): 4208-4220 [PMID: 34326620 DOI: 10.3748/wjg.v27.i26.4208] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhou W, Wang C, Chang J, Huang Y, Xue Q, Miao C, Wu P. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases. Front Pharmacol 2021;12:722728. [PMID: 34489709 DOI: 10.3389/fphar.2021.722728] [Reference Citation Analysis]
41 Murtha-Lemekhova A, Fuchs J, Ghamarnejad O, Nikdad M, Probst P, Hoffmann K. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis. Sci Rep 2021;11:13739. [PMID: 34215781 DOI: 10.1038/s41598-021-92888-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Shen Q, Xia Y, Yang L, Wang B, Peng J, Tang M. Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/2813521] [Reference Citation Analysis]
43 Jiang F, Xu H, Shi X, Han B, Chu Z, Xu B, Liu X. Dynamic Electrocardiogram under P Wave Detection Algorithm Combined with Low-Dose Betaloc in Diagnosis and Treatment of Patients with Arrhythmia after Hepatocarcinoma Resection. J Healthc Eng 2021;2021:6034180. [PMID: 34697566 DOI: 10.1155/2021/6034180] [Reference Citation Analysis]
44 Zhang S, He L, Bo C, Yang S, An Y, Li N, Zhao Y, Zhao L, Ma W, Zheng Z. Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus. Radiat Oncol 2021;16:149. [PMID: 34391452 DOI: 10.1186/s13014-021-01874-7] [Reference Citation Analysis]
45 Lopez-Lopez V, Garcia-Lopez J, Eshmuminov D, Brusadin R, Lopez-Conesa A, Martinez-Insfran L, Fernández-Fernández P, Robles-Campos R. Left renal vein graft and in situ hepatic perfusion in hepatectomy for complete tumor invasion of hepatic veins: hemodynamic optimization and surgical technique. Langenbecks Arch Surg 2022. [PMID: 35102435 DOI: 10.1007/s00423-022-02451-6] [Reference Citation Analysis]
46 Ye C, Zhang W, Pang Z, Wang W. Efficacy of liver cancer microwave ablation through ultrasonic image guidance under deep migration feature algorithm. Pak J Med Sci 2021;37:1693-8. [PMID: 34712308 DOI: 10.12669/pjms.37.6-WIT.4885] [Reference Citation Analysis]
47 Sun R, Zhao H, Huang S, Zhang R, Lu Z, Li S, Wang G, Aa J, Xie Y. Prediction of Liver Weight Recovery by an Integrated Metabolomics and Machine Learning Approach After 2/3 Partial Hepatectomy. Front Pharmacol 2021;12:760474. [PMID: 34916939 DOI: 10.3389/fphar.2021.760474] [Reference Citation Analysis]
48 Huang S, Wang S, Xie Y, He X, Yi X, Zhang J, Deng Z, Yin L. Application of NRS2002 in Preoperative Nutritional Screening for Patients with Liver Cancer. J Oncol 2021;2021:8943353. [PMID: 34518766 DOI: 10.1155/2021/8943353] [Reference Citation Analysis]
49 Lee J, Gong YX, Xie DP, Jeong H, Seo H, Kim J, Park YH, Sun HN, Kwon T. Anticancer Effect of ERM210 on Liver Cancer Cells Through ROS/Mitochondria-dependent Apoptosis Signaling Pathways. In Vivo 2021;35:2599-608. [PMID: 34410947 DOI: 10.21873/invivo.12542] [Reference Citation Analysis]
50 Jia C, Ge K, Xu S, Liu L, Weng J, Chen Y. Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomy. World J Surg Oncol 2019;17:167. [PMID: 31590665 DOI: 10.1186/s12957-019-1710-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Serrablo A, Giménez-Maurel T, Utrilla Fornals A, Serrablo L, Azoulay D. Current indications of ex-situ liver resection: A systematic review. Surgery 2022:S0039-6060(22)00230-6. [PMID: 35791978 DOI: 10.1016/j.surg.2022.04.002] [Reference Citation Analysis]
52 Bergquist JR, Li AY, Javadi CS, Lee B, Norton JA, Poultsides GA, Dua MM, Visser BC. Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB (Oxford) 2021:S1365-182X(21)00007-1. [PMID: 33563547 DOI: 10.1016/j.hpb.2021.01.006] [Reference Citation Analysis]
53 Sun M, Shang P, Bai J, Li S, Li M. High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer. J Clin Lab Anal 2021;35:e23633. [PMID: 33099812 DOI: 10.1002/jcla.23633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Chen Y, Wang G, Xu H, Wang H, Bai D. Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma. J Oncol 2021;2021:6629633. [PMID: 33603784 DOI: 10.1155/2021/6629633] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Wang S, Yang D, Kong W. Prediction of Overall Survival Rate in Patients With Hepatocellular Carcinoma Using an Integrated Model Based on Autophagy Gene Marker. Front Genet 2021;12:647309. [PMID: 33868382 DOI: 10.3389/fgene.2021.647309] [Reference Citation Analysis]
56 Wang S, Xiong Z, Liu Y, Leng Y, Deng H, Shen D, Meng X, Liu T. Efficacy and safety of acupuncture and moxibustion combined with the external application of traditional Chinese medicine in the treatment of primary liver cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27659. [PMID: 34713860 DOI: 10.1097/MD.0000000000027659] [Reference Citation Analysis]
57 Zhang G, Yun Y, Lin C, Li H. Predictive Value of MRI with Serum Lectin-Reactive Alpha-Fetoprotein for Liver Cancer Recurrence after Percutaneous Radiofrequency Ablation. Evid Based Complement Alternat Med 2022;2022:5132135. [PMID: 35911145 DOI: 10.1155/2022/5132135] [Reference Citation Analysis]
58 Lv R, Tian Y, Yu Z, Liu C. Clinical efficacy of computed tomography-guided microwave ablation sequential transcatheter arterial chemoembolization under edge calculation for primary liver cancer over 5 cm in diameter. J Supercomput. [DOI: 10.1007/s11227-021-04118-3] [Reference Citation Analysis]
59 Hung ML, Mcwilliams JP. Portal vein embolization prior to hepatectomy: Techniques, outcomes and novel therapeutic approaches. Int J Gastrointest Interv 2018;7:2-8. [DOI: 10.18528/gii180010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Zhao C, Sun J, Dang Z, Su Q, Yang J. Circ_0000775 Promotes the Migration, Invasion and EMT of Hepatic Carcinoma Cells by Recruiting IGF2BP2 to Stabilize CDC27. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153908] [Reference Citation Analysis]
61 Zhang Y, Tie Q, Bao Z, Shao Z, Zhang L. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E. Comput Math Methods Med 2021;2021:6468405. [PMID: 34812269 DOI: 10.1155/2021/6468405] [Reference Citation Analysis]
62 El-Ahwany E, Mansy SS, Zoheiry M, Mourad L, Mahmoud S, Abu-Taleb H, Hassanien M, Hassan M. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model. Ultrastruct Pathol 2020;44:203-10. [PMID: 32216509 DOI: 10.1080/01913123.2020.1744783] [Reference Citation Analysis]
63 Ou Y, Deng Y, Wang H, Zhang Q, Luo H, Hu P. Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells. Front Med (Lausanne) 2021;8:649279. [PMID: 33928106 DOI: 10.3389/fmed.2021.649279] [Reference Citation Analysis]
64 Liang Y, Li M, Huang Y, Guo B. An Integrated Strategy for Rapid Hemostasis during Tumor Resection and Prevention of Postoperative Tumor Recurrence of Hepatocellular Carcinoma by Antibacterial Shape Memory Cryogel. Small 2021;:e2101356. [PMID: 34382336 DOI: 10.1002/smll.202101356] [Reference Citation Analysis]
65 Wang Q, Tang M, Zhang S. Comparison of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a meta-analysis. ANZ J Surg 2021;91:E432-8. [PMID: 33404115 DOI: 10.1111/ans.16560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Nie C, Wang B, Wang B, Lv N, Yu R, Zhang E. Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma. Cancer Cell Int 2021;21:396. [PMID: 34315493 DOI: 10.1186/s12935-021-02105-5] [Reference Citation Analysis]
67 Mehrabi A, Ramouz A, Golriz M, Khajeh E, Hackert T, Müller-Stich B, Strobel O, Hoffmann K, Büchler MW; Liver Cancer Center Heidelberg (LCCH). Long-Term Outcomes of Mesohepatectomy for Centrally Located Liver Tumors: Two-Decade Single-Center Experience. J Am Coll Surg 2022;235:257-66. [PMID: 35839400 DOI: 10.1097/XCS.0000000000000209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Zhou W, Wang X, Chang J, Cheng C, Miao C. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34775884 DOI: 10.1080/10408363.2021.2002256] [Reference Citation Analysis]
69 Zhang JN, Wei F, Lei LH, Yang Y, Yang Y, Zhou WP. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis. Bioengineered 2021. [PMID: 34784846 DOI: 10.1080/21655979.2021.2006942] [Reference Citation Analysis]
70 Liang F, Ma F, Zhong J. Prognostic factors of patients after liver cancer surgery: Based on Surveillance, Epidemiology, and End Results database. Medicine (Baltimore) 2021;100:e26694. [PMID: 34397696 DOI: 10.1097/MD.0000000000026694] [Reference Citation Analysis]
71 Zhang C, Yang M, Ericsson AC. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Front Oncol 2020;10:524205. [PMID: 33163393 DOI: 10.3389/fonc.2020.524205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Wei L, Wang Z, Jing N, Lu Y, Yang J, Xiao H, Guo H, Sun S, Li M, Zhao D, Li X, Qi W, Zhang Y. Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma. Chin Med 2022;17:90. [PMID: 35907976 DOI: 10.1186/s13020-022-00645-0] [Reference Citation Analysis]
73 Chen W, Wu Z, Cao L. Hepatectomy is associated with survival in intrahepatic cholangiocarcinoma: An observational study by instrumental variable analysis. Medicine (Baltimore) 2021;100:e24147. [PMID: 33655908 DOI: 10.1097/MD.0000000000024147] [Reference Citation Analysis]
74 Tang Y, Jiang M, Jiang HM, Ye ZJ, Huang YS, Li XS, Qin BY, Zhou RS, Pan HF, Zheng DY. The Roles of circRNAs in Liver Cancer Immunity. Front Oncol 2020;10:598464. [PMID: 33614486 DOI: 10.3389/fonc.2020.598464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Tang G, Zhang L, Huang W, Wei Z. Probiotics or Synbiotics for Preventing Postoperative Infection in Hepatopancreatobiliary Cancer Patients: A Meta-Analysis of Randomized Controlled Trials. Nutr Cancer 2022;:1-11. [PMID: 35723061 DOI: 10.1080/01635581.2022.2089698] [Reference Citation Analysis]
76 Deng M, Li S, Mei J, Lin W, Zou J, Wei W, Guo R. High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma. Genes (Basel) 2021;12:876. [PMID: 34200261 DOI: 10.3390/genes12060876] [Reference Citation Analysis]
77 Li W, Ge J, Xie J, Yang J, Chen J, He T. LncRNA TUG1 Promotes Hepatocellular Carcinoma Migration and Invasion Via Targeting miR-137/AKT2 Axis. Cancer Biother Radiopharm 2020. [PMID: 32589479 DOI: 10.1089/cbr.2019.3297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Wang Y, Xu B, Zhou J, Wu X. Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy. J Gastrointest Oncol 2020;11:1322-32. [PMID: 33457004 DOI: 10.21037/jgo-20-472] [Reference Citation Analysis]
79 Zhou H, Su L, Liu C, Li B, Li H, Xie Y, Sun D. CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma. Onco Targets Ther 2019;12:7823-31. [PMID: 31576140 DOI: 10.2147/OTT.S219429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A, Orimo T, Kakisaka T, Kamachi H, Ito YM, Taketomi A. Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection. World J Gastrointest Surg 2022; 14(7): 670-684 [DOI: 10.4240/wjgs.v14.i7.670] [Reference Citation Analysis]
81 Chen L, Zeng F, Yao L, Fang T, Liao M, Long J, Xiao L, Deng G. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Cancer Med 2020;9:1451-61. [PMID: 31903730 DOI: 10.1002/cam4.2823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]